A European retrospective study in patients with MF and SS did not detect any differences in response by CD30 level or previous treatment, but suggested a potential association between lower disease stage and higher ORR4, as well as between LCT and skin ORR [102]. This evidence concerns the gene TNFRSF8 and mycosis fungoides.